Prosper Medical, from the founders of PlushCare, raises $16m seed led by FUSE

What Prosper does

Prosper describes itself as concierge-level primary care, supercharged by AI. Unlike most concierge or membership-based care, it says, it is not reserved for the ultra-wealthy: it is in-network with major insurance plans and available in all 50 states, and one membership covers the member and their children. Its physicians trained at a top-50 US medical school.

The company says AI supports clinicians by assembling medical records, analysing health data, ordering labs, writing prescriptions, sending specialist referrals and coordinating care. It said thousands of members joined within a few months of launch. Neither source gave pricing, a member count or headcount.

The founders

Ryan McQuaid is co-founder and chief executive, and James Wantuck, a physician, is co-founder and chief medical officer. Both previously founded PlushCare, which they sold to Accolade for $450m, HIT Consultant reported.

In their announcement they wrote that they are launching Prosper Medical to finish what they started with their previous company. McQuaid said that PlushCare taught them that making appointments easier was not enough.

What the money is for

Prosper will use the seed funding to expand its physician network, strengthen its AI platform and add services for members. The announcement did not name earlier funding.

How AI fits in

Pulse 2.0 reported that Prosper's AI supports physicians rather than replacing them, giving doctors relevant context before appointments, keeping information connected across patient interactions and organising data from records, labs, specialists and messages. It also helps coordinate test results, specialist referrals and communications, and flags health signals that could otherwise be missed between visits.

A Care Concierge Team handles administrative and coordination tasks outside physician visits. McQuaid said the real challenge is everything that happens after a patient leaves the visit, and that AI finally gives the company a way to deliver that level of care and personalisation at a scale that was not possible before.

The founders and the investor

Wantuck said medicine has always been at its best when a physician truly knows their patient, and that this relationship used to require either extraordinary luck or extraordinary wealth. Brendan Wales, a general partner at FUSE, said that after building and selling PlushCare the founders could have worked on almost anything, and instead came back to one of healthcare's most important unsolved problems.

Pulse 2.0 said the proceeds will fund physician recruiting, expansion into new markets and AI platform development. Neither source described membership pricing or the specific conditions Prosper treats.

Positioning

Prosper positions itself against traditional concierge medicine, which is usually paid for in cash by wealthy patients. By being in-network with major insurers, it argues, the model can reach a wider group. Neither the company nor the reports named the insurers or gave the cost of membership, so how the economics work remains unreported. The company did not give a headcount or a founding date.